Europe’s medicines watchdog said Monday it had begun evaluating the use of Pfizer BioNTech’s COVID-19 vaccine for 12- to 15-year-olds, after a similar request in the United States. Its possible authorisation for children is seen as a crucial step towards achieving herd immunity. The European Medicines Agency’s human medicines committee “will carry out an accelerated